Logoneurosis. Complete Remission. Clinical Document No. 001. Family System CITADEL 2060: METHODOLOGY "VOICE OF SLEEP MAMABEE 2026-2085"

Part of paid clinical trials in New York, New York.

Sponsor
Pisareva Citadel Group LLC
Study ID
NCT07628114
Status
Completed

Conditions

  • Logoneurosis

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Voice of Sleep MamaBee 2026-2085 Training Modules: Systemic work with brain neurons through training modules at the border of sleep. Restoration of the nervous system core in real time. — BEHAVIORAL
    Voice range constitutes 49-250 Hz. Active operational range 77-93 Hz. Family system Citadel 2060: training modules - fairy tales "The Voice of sleep Mama Bee 2026-2085", medical module "Doctrine: Voice of physician 2030-2060". Neurofoundation: work with brain neurons in own brain simulation on border of sleep occurs.

Study Details

Training Modules: Three fairy tales Doctrine "Voice of Sleep: MамаBee 2026-2085" Family System: "Citadel 2060" Systemic work with brain neurons through training modules at the border of sleep in clinical, psychological and strategic logic. Training modules of fairy tale in brain simulation, restoration of the nervous system core in real time. Strategic model of the generational horizon 2026-2085. Method Advantages: Autonomous, operates remotely without the physical presence of a psychologist. Eradicates clinical stress for the child.

Key Dates

Start date
Mar 21, 2025
Status verified
May 2026
Primary completion
May 24, 2026
Completion
May 24, 2026

Study Design

Enrollment
1 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Other: Citadel 2060 Family System
    Training Modules fairy tales: Doctrine "Voice of Sleep: MamaBee 2026-2085" Family System: "Citadel 2060" Systemic work with brain neurons through training modules at the border of sleep in clinical, psychological and strategic logic. Training modules of fairy tale in brain simulation, restoration of the nervous system core in real time. Strategic model of the generational horizon 2026-2085. Method Advantages: Autonomous, operates remotely without the physical presence of a psychologist. Eradicates clinical stress for the child

Primary Outcome Measure

Complete remission of logoneurosis [ Time Frame: 14 months (from March 26, 2025 to May 24, 2026). Listening to three fairy tales: 0, 3 and 6 months = fixation of result; Remaining period: observation, no setbacks occurred. ]

Locations (1)

FacilityCityStateZIPSite coordinators
Pisareva Citadel Group LLCNew YorkNew York10075-

Find similar trials in New York, NY